Eli Lilly’s weight loss drug Zepbound was found to reduce obstructive sleep apnea in adults with obesity, the drugmaker said in a release Wednesday.
Related Posts
Supreme Court signals it is likely to reject a challenge to abortion pill access
The Supreme Court hears arguments on whether to ma
How to Talk to Your Family About Their Heart Health History
Hypertrophic obstructive cardiomyopathy (HO